CuI and CuII complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action
- PMID: 29348049
- DOI: 10.1016/j.jinorgbio.2018.01.008
CuI and CuII complexes with phosphine derivatives of fluoroquinolone antibiotics - A comparative study on the cytotoxic mode of action
Abstract
In this paper, we present a comparative study on the cytotoxic mode of action of copper(I) and copper(II) complexes with phosphine derivatives of fluoroquinolone antibiotics (ciprofloxacin HCp and norfloxacin HNr). The in vitro cytotoxic activity of four new compounds was tested against two selected cancer cell lines. All complexes exhibited much better cytotoxicity against both cell lines than unmodified fluoroquinolone antibiotics, their phosphines (PCp, PNr), chalcogenide derivatives (oxides: OPCp, OPNr; sulfides: SPCp, SPNr and selenides: SePCp, SePNr) and previously described by us complexes with phosphines derived from different fluoroquinolones: lomefloxacin (HLm) and sparfloxacin (HSf) as well as cisplatin. Apoptosis, observed at a great predominance, was induced by all studied complexes. Importantly, it was concluded that coordination compounds with Cu(I) ion ([CuI-PNr] and [CuI-PCp]) were much more active than those with Cu(II) ion ([OPNr-CuII], [OPCp-CuII]), even though the highest efficacy to produce reactive oxygen species, participating in overall cytotoxicity, was proved for copper(II) complexes among all studied compounds. Herein, we discuss not only results obtained for copper(I)/(II) complexes with phosphines derived from HNr and HCp but we also compare them to previously described data for complexes with HLm and HSf derivatives. This is the first insight into a structure-activity relationship of copper complexes with phosphine derivatives of fluoroquinolone antibiotics.
Keywords: Apoptosis; Copper complexes; Fluoroquinolones; ROS production.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains.J Inorg Biochem. 2020 Sep;210:111124. doi: 10.1016/j.jinorgbio.2020.111124. Epub 2020 Jun 2. J Inorg Biochem. 2020. PMID: 32534287
-
Copper(I) complexes with phosphine derived from sparfloxacin. Part II: a first insight into the cytotoxic action mode.Dalton Trans. 2016 Mar 28;45(12):5052-63. doi: 10.1039/c5dt04011f. Dalton Trans. 2016. PMID: 26674970
-
Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes.Dalton Trans. 2018 Feb 6;47(6):1981-1992. doi: 10.1039/c7dt03917d. Dalton Trans. 2018. PMID: 29345262
-
Copper and Copper Complexes in Tumor Therapy.ChemMedChem. 2024 Jun 3;19(11):e202400060. doi: 10.1002/cmdc.202400060. Epub 2024 Mar 22. ChemMedChem. 2024. PMID: 38443744 Review.
-
Innovative Approaches in the Synthesis and Optimization of Copper Complexes for Antitumor Therapies: A Comprehensive Review.Molecules. 2025 May 9;30(10):2104. doi: 10.3390/molecules30102104. Molecules. 2025. PMID: 40430277 Free PMC article. Review.
Cited by
-
Liposomal Binuclear Ir(III)-Cu(II) Coordination Compounds with Phosphino-Fluoroquinolone Conjugates for Human Prostate Carcinoma Treatment.Inorg Chem. 2022 Dec 5;61(48):19261-19273. doi: 10.1021/acs.inorgchem.2c03015. Epub 2022 Nov 16. Inorg Chem. 2022. PMID: 36383699 Free PMC article.
-
Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells.Acta Pharmacol Sin. 2022 Mar;43(3):692-702. doi: 10.1038/s41401-021-00691-8. Epub 2021 May 25. Acta Pharmacol Sin. 2022. PMID: 34035487 Free PMC article.
-
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents.Molecules. 2024 Jul 27;29(15):3538. doi: 10.3390/molecules29153538. Molecules. 2024. PMID: 39124943 Free PMC article. Review.
-
Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review.Front Oncol. 2022 Jun 8;12:890337. doi: 10.3389/fonc.2022.890337. eCollection 2022. Front Oncol. 2022. PMID: 35756639 Free PMC article. Review.
-
Two out of Three Musketeers Fight against Cancer: Synthesis, Physicochemical, and Biological Properties of Phosphino CuI, RuII, IrIII Complexes.Pharmaceuticals (Basel). 2022 Jan 29;15(2):169. doi: 10.3390/ph15020169. Pharmaceuticals (Basel). 2022. PMID: 35215281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous